FDA Investigator Tenzin Jangchup

Tenzin Jangchup has conducted inspections on 42 sites in 6 countries as of 07 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
42
Last Inspection Date:
07 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
100000580
Countries of Inspections:
United States of America, Germany, France, China, India, Sweden
FDA Investigators that have inspected at least one site in common with Tenzin Jangchup:
Adaliz Santaliz Cruz, Alan M Barker, Alan P Kurtzberg, Althea A Williams, Andrew Le, Anthony J Ladner, Ariel Cruz Figueroa, Azza Talaat, Brian D Nicholson, Brittany R Laymon, Bruce H Mccullough, Carla R Hinz, Charles D Brown, Charles L Zhou, Charles R Cote, RIC, Cheryl A Grandinetti, Christine I Shaw, Christopher J Freebairn, Clinton J Lott, Colleen E Burke, Constance L Richard, Courtney R Ingalsbe, Courtney R Tiegs, Cynthia Jim, CSO, Dacia E Quick, Danial S Hutchison, Daniel Pst Laurent, David A Gonzalez, Daynia L Lashaway, Deborah S Hammond, Debra I Love, Debra Lboyd Seale, Devaughn Edwards, Dipesh K Shah, Dolores Harper, Dr. Zhou Chen (nmi), MD PhD, Duc Minh H Nguyen, Edith M Gonzalez, Edward M James, Eric L Dong, BS, Erik W Burrows, Erika V Butler, Farhana Khan, Felix Maldonado, Frank L Cordova, Frank S Sedzielarz, Frederick L Fricke, Gam S Zamil, Gerard T Schneider, Gina M Scholze, Ginger M Sykes, Gloria A Milster, Gregory R Brinsley, Guerlain Ulysse, Gwyn G Dickinson, Hanna L Potter, Haroon Vohra (NMI), Heather Akleimola Hulbert, Heriberto Negron Rivera, Howard A Burmester, Ian M Carrico, Isabel Y Espinosa, Ivan E Reyes, Jacob W Reynolds, James K Ireland, Jamie L Dion, Jamie L Port, Janis R Armedoriz, Jasjeet K Sekhon, Jeanne J Thai, Jee Chung, PhD, Jeffry A Bernhardt, Jennifer L Gustavus, Jennifer R Mathern, Jesse A Vazquez, Jesse P Romenesko, Jessica M Ector, Jiao Yang, PhD, Jill J Tillman, Jin M Kim, Joan A Loreng, Joel D Hustedt, John A Gonzalez, John Misock, Jonathan G Gayechuway, Jose Acruz Gonzalez, Jose R Hernandez, Joseph A Piechocki, Julia D Cartwright, Justin A Boyd, Karen A Wolnik, Karen Wolnik, Katherine Szestypalow, Kathryn M Mogen, Keith C Littrell, Kellia N Hicks, Kelly D Moore, Kent C Faul, Kham Phommachanh, Kimberley A Hoefen, Kristen E Szenderski, Kristy E Zuroski, Lauren N Howard, Lavender M Huskey, Lequita M Mayhew, Liming Zhang, Linda F Murphy, Linda M Cheny, Lisa Shin, Lori B Wikstrom, Marc A Jackson, Jr, Maria E Treadwell, Marie A Fadden, Marion W Nadeau, Marsha L Mccauley, Matthew B Casale, Matthew M Vernon, Matthew R Dionne, Michael A Charles, Michael J Kuchta, Michael Kuchta, Michael R Goga, Michele L Obert, Michele Perry Williams, Miguel A Martinez Perez, Minerva Rogers, Morie Alpha, Mra Munizn, Muralidhara B Gavini, PhD, Nadine Nanko Johnson, Nancy G Schmidt, Nathan M Jornod, Nayan J Patel, Nicholas P Diorio, Nicholas Z Lu, Nicole E Knowlton, Nicole S Williams, Oluwaseyi Ojinni, Patricia A Brown, Patricia A Cortez, Patricia A Maestas, Patricia Brown, Rafael Padilla, Rafeeq A Habeeb, Ramesh Raghavachari, Randy V Bong, Rebecca H Lee, Richard Jay Tucker, RS, Ricki A Chase, Robert J Ham, Robert Sharpnack, Russell J Glapion, Samina S Khan, Sandra A Hughes, Shalonda C Clifford, Sharon K Thoma, PharmD, Shererk, Susan D Yuscius, Tajah L Blackburn, Tamara J Umscheid, Tamara L Setzer, Teresa I Navas, Thai T Duong, Theressa B Smith, Timothy T Kapsala, Tracy K Li, Warren J Lopicka, Wendy A Good, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Yuanyuan Li, Yumi J Hiramine, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm

Tenzin Jangchup's Documents

Publish Date Document Type Title
March, 2017 FDA 483 Novartis Pharmaceuticals A. G. - Form 483, 2017-03-23
August, 2018 FDA 483 Mayo Clinic Pharmacy - Form 483, 2018-08-15
September, 2019 FDA 483 Recipharm Strängnäs AB - Form 483, 2019-09-06
May, 2017 FDA 483 Wise Pharmacy - Form 483, 2017-05-23
August, 2023 EIR Henan Dongtai Pharm Co., Ltd. - EIR, 2024-01-17
January, 2018 FDA 483 Beacon Promotions, Inc. - Form 483, 2018-01-12
August, 2018 FDA 483 Response Mayo Clinic Pharmacy - Form 483R, 2018-08-30
January, 2017 EIR Airgas Usa, LLC - EIR, 2017-01-26
May, 2016 FDA 483 Response Yusef Manufacturing Laboratories, LLC - Form 483R, 2016-06-03
May, 2018 FDA 483 Rockline Industries - Form 483, 2018-05-04
March, 2017 EIR Novartis Pharmaceuticals A. G. - EIR, 2017-03-23
October, 2017 FDA 483 Kingchem Laboratories Inc. - Form 483, 2017-10-20
March, 2019 FDA 483 APARNA ORGANICS LIMITED - Form 483, 2019-03-15
December, 2016 FDA 483 BLA Enterprises, LLC - Form 483, 2016-12-08
December, 2017 EIR AbbVie Inc. - EIR, 2017-12-15
May, 2016 FDA 483 Yusef Manufacturing Laboratories, LLC - Form 483, 2016-09-19
August, 2018 FDA 483 Morton Drug Company dba Morton LTC - Form 483, 2018-08-31
March, 2019 EIR APARNA ORGANICS LIMITED - EIR, 2019-03-15
December, 2017 FDA 483 AbbVie Inc. - Form 483, 2017-12-15
April, 2018 FDA 483 Fairview Compounding Phamacy - Form 483, 2018-04-18
May, 2019 EIR NorthStar Medical Radioisotopes, LLC - EIR, 2019-05-31
April, 2018 FDA 483 Response Fairview Compounding Phamacy - Form 483R, 2018-06-26
May, 2019 FDA 483 NorthStar Medical Radioisotopes, LLC - Form 483, 2019-05-31
December, 2015 FDA 483 OraLabs, Inc - Form 483, 2015-12-18
February, 2019 FDA 483 R.L.Fine Chem Private Limited - Form 483, 2019-02-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more